Prescriptions for short-acting hormonal methods, such as pills and injections, declined in the year after diabetes diagnosis<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
FRIDAY, March 26, 2021 (HealthDay News) — Women are are no more likely to use contraception after a diabetes diagnosis, according to a study published online March 18 in Primary Care Diabetes<\/em>.<\/p>\n Mara E. Murray Horwitz, M.D., from Harvard Medical School in Boston, and colleagues used private insurance data from nonpregnant women (aged 15 to 49 years; 2000 to 2014) to identify women with a new diabetes diagnosis (75,355 individuals) and a matched control group without diabetes (7.5 million individuals). Rates of prescription or procedural contraception use in the two groups were compared.<\/p>\n The researchers found that overall rates of contraception use did not increase in the year after diagnosis (absolute difference-in-difference, 0.4 percent). There was a decline noted in estrogen-containing and injectable contraceptives in the year after diagnosis (absolute difference-in-difference, \u00e2\u0088\u00922.2 and \u00e2\u0088\u00920.8 percent, respectively), although there were no corresponding increases for intrauterine contraception or subdermal implants.<\/p>\n “Our findings highlight the need for increased patient education, clinical support tools, and care coordination to improve access to family planning — including the full range of safe and effective contraceptive options — for women with diabetes,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n